Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

The Impact of Exclusive Use of Very Low Nicotine Cigarettes on Compensatory Smoking: An Inpatient Crossover Clinical Trial.

Smith TT, Koopmeiners JS, White CM, Denlinger-Apte RL, Pacek LR, De Jesús VR, Wang L, Watson C, Blount BC, Hatsukami DK, Benowitz NL, Donny EC, Carpenter MJ.

Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):880-886. doi: 10.1158/1055-9965.EPI-19-0963. Epub 2020 Feb 26.

PMID:
32102910
2.

Mouth-Level Nicotine Intake Estimates from Discarded Filter Butts to Examine Compensatory Smoking in Low Nicotine Cigarettes.

Smith TT, Koopmeiners JS, Hatsukami DK, Tessier KM, Benowitz NL, Murphy SE, Strasser AA, Tidey JW, Blount BC, Valentin L, Bravo Cardenas R, Watson C, Pirkle JL, Donny EC.

Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):643-649. doi: 10.1158/1055-9965.EPI-19-0905. Epub 2020 Feb 26.

PMID:
32102909
3.

Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

Carroll DM, Murphy SE, Benowitz NL, Strasser AA, Kotlyar M, Hecht SS, Carmella SG, McClernon FJ, Pacek LR, Dermody SS, Vandrey RG, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2020 Apr;29(4):871-879. doi: 10.1158/1055-9965.EPI-19-0644. Epub 2020 Feb 12.

PMID:
32051195
4.

Dynamic borrowing in the presence of treatment effect heterogeneity.

Kotalik A, Vock DM, Donny EC, Hatsukami DK, Koopmeiners JS.

Biostatistics. 2020 Jan 24. pii: kxz066. doi: 10.1093/biostatistics/kxz066. [Epub ahead of print]

PMID:
31977040
5.

The Role of Compensation in Nicotine Reduction.

Benowitz NL, Donny EC, Edwards KC, Hatsukami D, Smith TT.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S16-S18. doi: 10.1093/ntr/ntz120.

6.

The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.

Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S73-S80. doi: 10.1093/ntr/ntz158.

7.

Effects of 6-Week Use of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.

Tidey JW, Colby SM, Denlinger-Apte RL, Goodwin C, Cioe PA, Cassidy RN, Swift RM, Lindgren BR, Rubin N, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S38-S45. doi: 10.1093/ntr/ntz133.

8.

The Importance of Estimating Causal Effects for Evaluating a Nicotine Standard for Cigarettes.

Koopmeiners JS, Vock DM, Boatman JA, Carroll D, Colby SM, Donny EC, Hatsukami DK, Luo X, Tidey JW.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S22-S25. doi: 10.1093/ntr/ntz119.

9.

Using Product Standards to Render the Most Harmful Tobacco Products Minimally Addictive: Maximum Nicotine Level, Non-Nicotine Constituents, and Scope.

White CM, Pickworth WB, Sved AF, Donny EC.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S13-S15. doi: 10.1093/ntr/ntz121. No abstract available.

10.

Effects of Very Low Nicotine Content Cigarettes on Smoking Behavior and Biomarkers of Exposure in Menthol and Non-menthol Smokers.

Denlinger-Apte RL, Kotlyar M, Koopmeiners JS, Tidey JW, Luo X, Benowitz NL, Jensen JA, Ikuemonisan JO, Pacek LR, Smith TT, Vandrey R, Donny EC, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S63-S72. doi: 10.1093/ntr/ntz160.

11.

Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior.

Robinson JD, Kypriotakis G, al'Absi M, Denlinger-Apte RL, Drobes DJ, Leischow S, McClernon FJ, Pacek LR, Severson H, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK.

Nicotine Tob Res. 2019 Nov 8. pii: ntz209. doi: 10.1093/ntr/ntz209. [Epub ahead of print]

PMID:
31701153
12.

Smoking topography characteristics during a six-week trial of very low nicotine content cigarettes in smokers with serious mental illness.

Denlinger-Apte RL, Donny EC, Lindgren BR, Rubin N, Goodwin C, DeAtley T, Colby SM, Cioe PA, Hatsukami DK, Tidey JW.

Nicotine Tob Res. 2019 Oct 19. pii: ntz198. doi: 10.1093/ntr/ntz198. [Epub ahead of print]

PMID:
31628475
13.

Cigarette Smokers vs. Co-users of Cannabis and Cigarettes: Exposure to Toxicants.

Meier E, Vandrey R, Rubin N, Pacek LR, Jensen JA, Donny EC, Hecht SS, Carmella SG, Murphy SE, Luo X, Stepanov I, Ikuemonisan J, Severson H, al'Absi M, Hatsukami DK.

Nicotine Tob Res. 2019 Oct 16. pii: ntz199. doi: 10.1093/ntr/ntz199. [Epub ahead of print]

PMID:
31616939
14.

Impact of Brief Nicotine Messaging on Nicotine-Related Beliefs in a U.S. Sample.

Villanti AC, West JC, Mays D, Donny EC, Cappella JN, Strasser AA.

Am J Prev Med. 2019 Oct;57(4):e135-e142. doi: 10.1016/j.amepre.2019.05.015.

PMID:
31542145
15.

Randomized Trial of Low-Nicotine Cigarettes and Transdermal Nicotine.

Smith TT, Koopmeiners JS, Tessier KM, Davis EM, Conklin CA, Denlinger-Apte RL, Lane T, Murphy SE, Tidey JW, Hatsukami DK, Donny EC.

Am J Prev Med. 2019 Oct;57(4):515-524. doi: 10.1016/j.amepre.2019.05.010.

PMID:
31542129
16.

Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers.

St Helen G, Benowitz NL, Ko J, Jacob P, Gregorich SE, Pérez-Stable EJ, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

J Expo Sci Environ Epidemiol. 2019 Aug 12. doi: 10.1038/s41370-019-0159-9. [Epub ahead of print]

PMID:
31406274
17.

Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.

Ribisl KM, Hatsukami DK, Huang J, Williams RS, Donny EC.

Am J Public Health. 2019 Jul;109(7):1007-1014. doi: 10.2105/AJPH.2019.305067.

PMID:
31166743
18.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 Oct;114(10):1824-1833. doi: 10.1111/add.14695. Epub 2019 Jul 8.

PMID:
31140663
19.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

20.

Nicotine Self-administration Is Not Increased in the Methylazoxymethanol Acetate Rodent Model of Schizophrenia.

Weeks JJ, Rupprecht LE, Grace AA, Donny EC, Sved AF.

Nicotine Tob Res. 2020 Feb 6;22(2):204-212. doi: 10.1093/ntr/ntz048.

PMID:
30899959
21.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

22.

Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.

Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC.

Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.

PMID:
30385649
23.

The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller.

Hatsukami DK, Donny EC.

Nicotine Tob Res. 2019 Feb 18;21(3):338-339. doi: 10.1093/ntr/nty195. No abstract available.

24.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

25.

Cigarette Management System: An operating procedures guide to obtaining and managing investigational tobacco products for regulatory science research.

Kazi A, Fazzi A, Krebs NM, Merchlinski AJ, Kline B, Veldheer S, Richie JP Jr, Foulds J, Lane T, Donny EC, Muscat JE.

Contemp Clin Trials Commun. 2018 May 5;11:69-74. doi: 10.1016/j.conctc.2018.05.006. eCollection 2018 Sep.

26.

Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.

Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Koopmeiners JS, Hatsukami D, Donny EC.

Nicotine Tob Res. 2019 Jun 21;21(7):962-969. doi: 10.1093/ntr/nty079.

27.

Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.

Smith TT, Hatsukami DK, Benowitz NL, Colby SM, McClernon FJ, Strasser AA, Tidey JW, White CM, Donny EC.

Prev Med. 2018 Dec;117:8-14. doi: 10.1016/j.ypmed.2018.03.021. Epub 2018 Mar 29.

28.

Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC.

Exp Clin Psychopharmacol. 2018 Jun;26(3):223-232. doi: 10.1037/pha0000179. Epub 2018 Mar 5.

29.

Self-administered nicotine increases fat metabolism and suppresses weight gain in male rats.

Rupprecht LE, Kreisler AD, Spierling SR, de Guglielmo G, Kallupi M, George O, Donny EC, Zorrilla EP, Sved AF.

Psychopharmacology (Berl). 2018 Apr;235(4):1131-1140. doi: 10.1007/s00213-018-4830-y. Epub 2018 Jan 21.

PMID:
29354872
30.

Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks.

Pacek LR, Joseph McClernon F, Denlinger-Apte RL, Mercincavage M, Strasser AA, Dermody SS, Vandrey R, Smith TT, Nardone N, Hatsukami DK, Koopmeiners JS, Kozink RV, Donny EC.

Tob Control. 2018 Jul;27(4):420-426. doi: 10.1136/tobaccocontrol-2017-053689. Epub 2017 Jul 22.

31.

Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.

Boatman JA, Vock DM, Koopmeiners JS, Donny EC.

Biostatistics. 2018 Jan 1;19(1):103-118. doi: 10.1093/biostatistics/kxx029.

32.

Animal Research on Nicotine Reduction: Current Evidence and Research Gaps.

Smith TT, Rupprecht LE, Denlinger-Apte RL, Weeks JJ, Panas RS, Donny EC, Sved AF.

Nicotine Tob Res. 2017 Sep 1;19(9):1005-1015. doi: 10.1093/ntr/ntx077.

33.

Cigarette Nicotine Content as a Moderator of the Relationship Between Negative Affect and Smoking.

Robinson JD, Kypriotakis G, Karam-Hage M, Green CE, Hatsukami DK, Cinciripini PM, Donny EC.

Nicotine Tob Res. 2017 Sep 1;19(9):1080-1086. doi: 10.1093/ntr/ntx068.

34.

Low Cotinine Glucuronidation Results in Higher Serum and Saliva Cotinine in African American Compared to White Smokers.

Murphy SE, Sipe CJ, Choi K, Raddatz LM, Koopmeiners JS, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1093-1099. doi: 10.1158/1055-9965.EPI-16-0920. Epub 2017 Mar 6.

35.

Self-administered nicotine differentially impacts body weight gain in obesity-prone and obesity-resistant rats.

Rupprecht LE, Smith TT, Donny EC, Sved AF.

Physiol Behav. 2017 Jul 1;176:71-75. doi: 10.1016/j.physbeh.2017.02.007. Epub 2017 Feb 9.

36.

Attrition during a randomized controlled trial of reduced nicotine content cigarettes as a proxy for understanding acceptability of nicotine product standards.

Mercincavage M, Wileyto EP, Saddleson ML, Lochbuehler K, Donny EC, Strasser AA.

Addiction. 2017 Jun;112(6):1095-1103. doi: 10.1111/add.13766. Epub 2017 Feb 23.

37.

Low Nicotine Content Descriptors Reduce Perceived Health Risks and Positive Cigarette Ratings in Participants Using Very Low Nicotine Content Cigarettes.

Denlinger-Apte RL, Joel DL, Strasser AA, Donny EC.

Nicotine Tob Res. 2017 Oct 1;19(10):1149-1154. doi: 10.1093/ntr/ntw320.

38.

Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes.

Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, Donny EC.

Tob Control. 2017 Mar;26(e1):e43-e48. doi: 10.1136/tobaccocontrol-2016-053301. Epub 2016 Nov 17.

39.

Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Henningfield JE, Smith TT, Kleykamp BA, Fant RV, Donny EC.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3829-3848. Epub 2016 Oct 21. Review.

40.

Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: further results from a multi-site clinical trial.

Smith TT, Cassidy RN, Tidey JW, Luo X, Le CT, Hatsukami DK, Donny EC.

Addiction. 2017 Feb;112(2):349-359. doi: 10.1111/add.13636. Epub 2016 Nov 28.

41.

Reducing the nicotine content of combusted tobacco products sold in New Zealand.

Donny EC, Walker N, Hatsukami D, Bullen C.

Tob Control. 2017 Mar;26(e1):e37-e42. doi: 10.1136/tobaccocontrol-2016-053186. Epub 2016 Sep 26.

PMID:
27672126
42.

Characterizing the relationship between increases in the cost of nicotine and decreases in nicotine content in adult male rats: implications for tobacco regulation.

Smith TT, Rupprecht LE, Sved AF, Donny EC.

Psychopharmacology (Berl). 2016 Dec;233(23-24):3953-3964. Epub 2016 Sep 14.

43.

Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.

Tidey JW, Pacek LR, Koopmeiners JS, Vandrey R, Nardone N, Drobes DJ, Benowitz NL, Dermody SS, Lemieux A, Denlinger RL, Cassidy R, al'Absi M, Hatsukami DK, Donny EC.

Nicotine Tob Res. 2017 Jan;19(1):59-67. Epub 2016 Aug 3.

44.

Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use.

Pacek LR, Vandrey R, Dermody SS, Denlinger-Apte RL, Lemieux A, Tidey JW, McClernon FJ, Bangdiwala AS, Drobes DJ, al'Absi M, Strasser AA, Koopmeiners JS, Hatsukami DK, Donny EC.

Drug Alcohol Depend. 2016 Oct 1;167:228-32. doi: 10.1016/j.drugalcdep.2016.08.620. Epub 2016 Aug 28.

45.

Reduced nicotine content cigarettes, e-cigarettes and the cigarette end game.

Benowitz NL, Donny EC, Hatsukami DK.

Addiction. 2017 Jan;112(1):6-7. doi: 10.1111/add.13534. Epub 2016 Aug 23. No abstract available.

46.

Estimations and predictors of non-compliance in switchers to reduced nicotine content cigarettes.

Nardone N, Donny EC, Hatsukami DK, Koopmeiners JS, Murphy SE, Strasser AA, Tidey JW, Vandrey R, Benowitz NL.

Addiction. 2016 Dec;111(12):2208-2216. doi: 10.1111/add.13519. Epub 2016 Aug 1.

47.

Self-Administered Nicotine Suppresses Body Weight Gain Independent of Food Intake in Male Rats.

Rupprecht LE, Smith TT, Donny EC, Sved AF.

Nicotine Tob Res. 2016 Sep;18(9):1869-1876. doi: 10.1093/ntr/ntw113. Epub 2016 May 18.

48.

Nicotine Enhances Footshock- and Lithium Chloride-Conditioned Place Avoidance in Male Rats.

Buffalari DM, Mollica JK, Smith TT, Schassburger RL, Rinaman L, Thiels E, Donny EC, Sved AF.

Nicotine Tob Res. 2016 Sep;18(9):1920-3. doi: 10.1093/ntr/ntw098. Epub 2016 May 13.

49.

Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt.

Sweitzer MM, Geier CF, Addicott MA, Denlinger R, Raiff BR, Dallery J, McClernon FJ, Donny EC.

Neuropsychopharmacology. 2016 Sep;41(10):2521-9. doi: 10.1038/npp.2016.56. Epub 2016 Apr 19.

50.

Threshold dose for discrimination of nicotine via cigarette smoking.

Perkins KA, Kunkle N, Karelitz JL, Michael VC, Donny EC.

Psychopharmacology (Berl). 2016 Jun;233(12):2309-17. doi: 10.1007/s00213-016-4281-2. Epub 2016 Apr 2.

Supplemental Content

Loading ...
Support Center